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The Association of Vitamin D Receptor Gene BsmI Polymorphism with Multiple 
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Background & Aims: 1,25-dihydroxyvitamin D3 (1,25 (OH)2 D3), the biologically active form of 
vitamin D, exerts an immunosuppressive effect through binding to its specific nuclear receptor. The 
present case-control study was done to examine the possible association of BsmI polymorphism in 
vitamin D receptor gene (VDR gene) with severity of multiple sclerosis (MS).  
Methods: 267 Iranian patients with MS and 292 ethnically and sex matched controls were included 
in this study. BsmI polymorphism in VDR gene was assessed by PCR-RFLP method.  
Results: No differences in the allelic distribution were observed in the patients as compared to the 
controls. Also no difference in genotype distribution of VDR-BsmI polymorphism was observed 
between patients and controls (p=0.43).  
Conclusion: Considering the significance of vitamin D3 as an immune system regulator and its 
inhibitory effects on MS, investigation on other VDR gene polymorphisms is recommended.  
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